News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Proteomics International Laboratories.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX health stocks: Proteomics tumbles 22pc on delayed product launch, Race hits 10mth highs
News
Top 10 at 10: AI, big gold hits, and a $65m cash windfall
News
Hot Money Monday: ‘Cut losses and let winners run’ – advice from legendary momentum trader Paul Tudor Jones
Health & Biotech
ASX Health Stocks: Neuren’s sales come in at top of guidance range, crushing short seller’s claims
News
Market Highlights: Bitcoin up again, Microsoft makes another huge AI bet, and 5 ASX small caps to watch
Health & Biotech
ASX Health Stocks: Singular Health shoots 60pc through the roof after breakthrough deal in US
ScoPo’s Powerplays: Nanosonics ‘in the doghouse’, but ASX health stocks are largely being good boys
Health & Biotech
ScoPo’s Powerplays: ASX healthcare rises in Christmas rally as EBOS ups stake in Transmedic
Health & Biotech
ScoPo gives his NINE picks to fill the Christmas stocking with some ASX health stocks
Health & Biotech
ASX Health Stocks: Neuren to start Phase 2 trial soon; Proteomics expands footprint in South America
Health & Biotech
ASX Health Stocks: Mesoblast partners up for pivotal trial, Alterity in $4.8 million cap raise
Health & Biotech
ASX Biotech September Winners: Healthcare down 5pc, but experts say it’s still best sector in a recession
News
In Case You Missed It: Medicare milestone and provisional ports approval
News
ASX Health Stocks: Proteomics soars 13pc after US sets reimbursement price for PromarkerD
News
Top 10 at 11: It’s a mixed up kinda morning, but we’re moving in the right direction… for now
Health & Biotech
2023 ASX biotech darling Neuren among sector stocks with upcoming catalysts
Health & Biotech